Senior insider sale
Chief Development Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$2.35M
60K shares
What this filing means
GUYER WILLIAM plans to sell 60K shares of CORCEPT THERAPEUTICS INC valued at approximately $2.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0001973251-26-000012
Officer· Chief Development Officer
Since Aug 2021
60K
Shares to sell
$2.35M
Approx. market value
20K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/7/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/7/2026 | Stock Option Exercise Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
11.77K
Market value
$423.7K
3/20/2026
—Completed
Units to sell
8.23K
Market value
$296.3K
3/4/2026
—Completed
Units to sell
20K
Market value
$817.3K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$817.0K
4/7/2026
Total
Units
60K
Value
$2.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/20/2026 | 11.77K | $423.7K | — | Completed |
3/4/2026 | 8.23K | $296.3K | — | Completed |
2/3/2026 | 20K | $817.3K | — | Completed |
| Planned — Approximate Date | ||||
4/7/2026 | 20K | $817.0K | NASDAQ | Planned |
| Total | 60K | $2.35M | ||